Acute treatment of migraine: quo vadis?
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1329821
Abstract: Migraine represents the third cause of disability in the worldwide population aged under 50 years. Facing this enormous social impact, only onabotulinumtoxinA has been evaluated, on serendipity basis, as effective chronic migraine preventative treatment [1].… read more here.
Keywords: migraine; treatment migraine; quo vadis; treatment ... See more keywords